stockrowAbsci Corporation (ABSI) vs Sarepta Therapeutics, Inc. (SRPT)
- Absci Corporation ABSI 10.13 +1.60%
- Sarepta Therapeutics, Inc. SRPT 16.56 +0.85%
Absci Corporation and Sarepta Therapeutics, Inc. are both Biotechnology companies. Absci Corporation and Sarepta Therapeutics, Inc. are of similar size ($1.8B and $1.7B). Absci Corporation has negative trailing earnings, so its P/E is not meaningful; Sarepta Therapeutics, Inc. trades at 186×. Sarepta Therapeutics, Inc. grew revenue faster over the last twelve months: −19.0% against −62.3%. Sarepta Therapeutics, Inc. has the higher net margin (0.75% vs −7,756.4%) and the higher return on invested capital (−2.26% vs −174.7%). Across the 18 metrics below, Sarepta Therapeutics, Inc. leads on 14 and Absci Corporation on 4.
Valuation
Profitability
| Metric | ABSI | SRPT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 56.79% | 68.51% |
| Operating margin | (8,084.50%) | (2.50%) | 0.00% |
| Net margin | (7,756.37%) | 0.75% | 0.00% |
| Free cash flow margin | (6,969.83%) | 8.79% | 0.00% |
| Return on equity | (57.72%) | 1.04% | (50.12%) |
| Return on assets | (50.57%) | 0.44% | (45.12%) |
| Return on invested capital | (174.74%) | (2.26%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack